InvestorsHub Logo
Followers 826
Posts 119569
Boards Moderated 14
Alias Born 09/05/2002

Re: None

Friday, 10/02/2020 5:20:17 PM

Friday, October 02, 2020 5:20:17 PM

Post# of 1162
Yervoy/Opdivo doesn’t show statsig RFS benefit in adjuvant melanoma compared to Opdivo monotherapy:

https://www.businesswire.com/news/home/20201002005482/en

This was the CHECKMATE-915 study.

“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent BMY News